Annals of Clinical Biochemistry > Volume 46, Number 5 > Pp. 373-376

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: acb.2009.009008v1 46/5/373    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Yeo, C.-P. Articles by Jacob, E. PubMed PubMed Citation Social Bookmarking                      What's this?

Original Articles

Haemoglobin A1c: evaluation of a new HbA1c point-of-care analyser Bio-Rad in2it in comparison with the DCA 2000 and central laboratory analysers

Chin-Pin Yeo, Carol Hui-Chen Tan and Edward Jacob

Clinical Biochemistry Laboratories, Department of Pathology, Singapore General Hospital, Singapore, Singapore

Corresponding author: Dr Chin-Pin Yeo. Email: yeo.chin.pin{at}sgh.com.sg

Background: Point-of-care-testing (POCT) of haemoglobin Alc (HbA1c) is popular due to its fast turnaround of results in the outpatient setting. The aim of this project was to evaluate the performance of a new HbA1c POCT analyser, the Bio-Rad in2it, and compare it with the Siemens DCA 2000, Bio-Rad Variant II and Roche Tina-quant HbA1c Gen 2 assay on the cobas c501.

Methods: Imprecision of the four methods were compared by computing total imprecision from within-run and between-run data. A total of 80 samples were also compared and analysed by Deming regression and Altman–Bland difference test.

Results: Study of total imprecision of the in2it at HBA1c levels of 6.0% and 10.4% produced a coefficient of variation (%CV) of 3.8% and 3.7%, respectively. These results were more favourable as compared with the DCA 2000 but did not match the low imprecision of the central laboratory methods, the Bio-Rad Variant II and the Roche cobas c501. Comparison between the in2it and the central laboratory analysers, Bio-Rad variant II and cobas c501, revealed positive bias of 12% and 10%, respectively, supported by corresponding Deming regression equation slopes of +1.18 and +1.14. Comparison between the DCA 2000 and the central laboratory analysers revealed a bias that became increasingly positive with rising HbA1c concentrations with Deming regression analysis also revealing proportional and constant differences.

Conclusions: The in2it is a suitable POCT analyser for HbA1c but its less than ideal precision performance and differences with the central laboratory analysers must be communicated to and noted by the users.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?